Is AbbVie a good stock?
Apr 14, 2022 · AbbVie's stock was trading at $84.85 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ABBV stock has increased by 97.2% and is now trading at $167.31. View which stocks have been most impacted by COVID-19.
Why did AbbVie stock drop?
102 rows · Discover historical prices for ABBV stock on Yahoo Finance. View daily, weekly or monthly format back to when AbbVie Inc. stock was issued.
When will AbbVie stock split?
MarketWatch: Stock Market News - Financial News - MarketWatch
When is abbv dividend paid?
AbbVie ( NYSE:ABBV ) looks weak at resistance and may be due for a drop in the coming weeks. Pretty strong bearish divergence. Insiders selling almost $16 million worth of shares in the past month at an average of $147.87 (source: OpenInsider). If this starts to drop, support points are the 50 EMA (yellow line), $135-$136, and then the support lines / 200 EMA....
Does AbbVie have a dividend?
(NYSE: ABBV) today declared a quarterly cash dividend of $1.41 per share. The cash dividend is payable May 16, 2022 to stockholders of record at the close of business on April 15, 2022. Since the company's inception in 2013, AbbVie has increased its dividend by more than 250 percent.Feb 17, 2022
What is ABBV stock price prediction?
The 20 analysts offering 12-month price forecasts for Abbvie Inc have a median target of 165.50, with a high estimate of 192.00 and a low estimate of 115.00. The median estimate represents a +2.08% increase from the last price of 162.13.
How high will Chevron stock go?
Chevron Corp (NYSE:CVX) The 25 analysts offering 12-month price forecasts for Chevron Corp have a median target of 180.00, with a high estimate of 213.00 and a low estimate of 130.00. The median estimate represents a +4.94% increase from the last price of 171.52.
Is AbbVie a Buy Sell or Hold?
AbbVie has received a consensus rating of Buy. The company's average rating score is 2.75, and is based on 12 buy ratings, 4 hold ratings, and no sell ratings.
Is AbbVie a buy right now?
16 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for AbbVie in the last year. There are currently 4 hold rat...
How has AbbVie's stock price been impacted by COVID-19?
AbbVie's stock was trading at $84.85 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since th...
When is AbbVie's next earnings date?
AbbVie is scheduled to release its next quarterly earnings announcement on Friday, April 29th 2022. View our earnings forecast for AbbVie .
How were AbbVie's earnings last quarter?
AbbVie Inc. (NYSE:ABBV) issued its quarterly earnings data on Wednesday, February, 2nd. The company reported $3.31 earnings per share for the quart...
How often does AbbVie pay dividends? What is the dividend yield for AbbVie?
AbbVie announced a quarterly dividend on Thursday, February 17th. Stockholders of record on Friday, April 15th will be given a dividend of $1.41 pe...
Is AbbVie a good dividend stock?
AbbVie pays an annual dividend of $5.64 per share and currently has a dividend yield of 3.78%. AbbVie has been increasing its dividend for 50 conse...
What guidance has AbbVie issued on next quarter's earnings?
AbbVie updated its FY 2022 earnings guidance on Monday, February, 21st. The company provided earnings per share (EPS) guidance of $14.000-$14.200 f...
What price target have analysts set for ABBV?
16 brokers have issued 1-year target prices for AbbVie's shares. Their forecasts range from $122.00 to $180.00. On average, they expect AbbVie's st...
Who are AbbVie's key executives?
AbbVie's management team includes the following people: Richard A. Gonzalez , Chairman & Chief Executive Officer ( LinkedIn Profile ) Michael E....
Is AbbVie a buy right now?
What stocks does MarketBeat like better than AbbVie?
16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AbbVie in the last twelve months. There are currently 1 sell rating, 2 hold ratings and 13 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" AbbVie stock.#N#View analyst ratings for AbbVie or view top-rated stocks.
When is AbbVie's next earnings date?
Wall Street analysts have given AbbVie a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but AbbVie wasn't one of them.
How were AbbVie's earnings last quarter?
AbbVie is scheduled to release its next quarterly earnings announcement on Friday, October 29th 2021.#N#View our earnings forecast for AbbVie.
How has AbbVie's stock price been impacted by COVID-19?
AbbVie Inc. (NYSE:ABBV) issued its quarterly earnings data on Thursday, July, 29th. The company reported $3.11 EPS for the quarter, beating analysts' consensus estimates of $3.09 by $0.02. The firm had revenue of $13.96 billion for the quarter, compared to analysts' expectations of $13.64 billion.
How often does AbbVie pay dividends? What is the dividend yield for AbbVie?
AbbVie's stock was trading at $84.85 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, ABBV stock has increased by 26.7% and is now trading at $107.48.#N#View which stocks have been most impacted by COVID-19.
Is AbbVie a good dividend stock?
AbbVie announced a quarterly dividend on Friday, September 10th. Shareholders of record on Friday, October 15th will be given a dividend of $1.30 per share on Monday, November 15th. This represents a $5.20 dividend on an annualized basis and a dividend yield of 4.84%. The ex-dividend date is Thursday, October 14th.#N#View AbbVie's dividend history.
Recently Viewed Tickers
AbbVie pays an annual dividend of $5.20 per share and currently has a dividend yield of 4.87%. ABBV has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio of AbbVie is 49.24%. This payout ratio is at a healthy, sustainable level, below 75%.
AbbVie Inc
Visit a quote page and your recently viewed tickers will be displayed here.
What is Abbvie Inc?
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products.
Is ABBV forming a double top pattern?
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
Signals & Forecast
ABBV is forming a double top pattern and has posted shorter term lower highs, along with lower lows. I suspect this will trend down to the 110 area, that will act as the neckline to the double top
Support, Risk & Stop-loss
There are few to no technical positive signals at the moment. The AbbVie Inc stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average.
Is AbbVie Inc stock A Buy?
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
